The focus of this paper is India. In line with TRIPS India has introduced a product patent regime in pharmaceuticals …

In the context of the TRIPS agreement and the accompanying debate about the merits of the requirement to enforce … product patents for pharmaceuticals, this paper provides a rigorously-derived estimate of the possible impact of …-bacterials (i.e., antibiotics) in the Indian pharmaceuticals market. These estimates are then used to carry out counterfactual …

right, strong government research institutes and private sector enterprises which have invested in innovation. The TRIPS …

This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …

TRIPs driven environment. …

TRIPS is a reality and India has to rework its patent law to conform to it. But that does not mean that we have a … patent law that provides for TRIPS plus rules. Our interest lies in taking full advantage of any flexibility available in the …

-Romande]. URL:[http://www.css-romande.ch/downloads/trips+/cssr_AdpicPlus_en.pdf]. …

countries via licensing is analyzed. Using panel data for the post-TRIPs period 1995-2005, it is found that stronger protection …